Chevy Chase Trust Holdings, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Chevy Chase Trust Holdings, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$41,000
+13.9%
10,0000.0%0.00%
Q4 2021$36,0000.0%10,0000.0%0.00%
Q3 2021$36,000
-18.2%
10,0000.0%0.00%
Q2 2021$44,000
+7.3%
10,0000.0%0.00%
Q1 2021$41,000
+2.5%
10,0000.0%0.00%
Q4 2020$40,000
+48.1%
10,0000.0%0.00%
Q3 2020$27,000
-3.6%
10,0000.0%0.00%
Q2 2020$28,000
+16.7%
10,0000.0%0.00%
Q1 2020$24,000
-48.9%
10,0000.0%0.00%
Q4 2019$47,000
+42.4%
10,0000.0%0.00%
Q3 2019$33,0000.0%10,0000.0%0.00%
Q2 2019$33,000
-17.5%
10,000
-33.3%
0.00%
Q1 2019$40,000
-2.4%
15,0000.0%0.00%
Q4 2018$41,000
-18.0%
15,0000.0%0.00%
Q3 2018$50,000
+28.2%
15,0000.0%0.00%
Q2 2018$39,000
+18.2%
15,0000.0%0.00%
Q1 2018$33,000
+10.0%
15,0000.0%0.00%
Q4 2017$30,000
-38.8%
15,0000.0%0.00%
Q3 2017$49,00015,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,671,956$5,384,0003.43%
ARMISTICE CAPITAL, LLC 5,700,000$18,354,0002.34%
Rubric Capital Management LP 3,188,600$10,267,0002.12%
Broadfin Capital, LLC 4,803,528$15,467,0001.88%
THOMPSON DAVIS & CO., INC. 192,734$621,0001.00%
Asymmetry Capital Management, L.P. 199,655$643,0000.76%
Perceptive Advisors 4,267,253$13,741,0000.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 946,987$3,049,0000.21%
Brown Advisory Securities, LLC 275,000$886,0000.20%
EAM Investors, LLC 251,619$810,0000.13%
View complete list of ANTARES PHARMA INC shareholders